Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
+0.04 (0.45%)
At close: Dec 20, 2024, 4:00 PM
9.17
+0.16 (1.82%)
After-hours: Dec 20, 2024, 6:30 PM EST
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $700.65 million as of December 20, 2024. Its market cap has decreased by -14.78% in one year.
Market Cap
700.65M
Enterprise Value
261.98M
1-Year Change
-14.78%
Ranking
Category
Stock Price
$9.01
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $700.65M, an increase of 516.23%. That is a compound annual growth rate of 22.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 697.50M | -34.69% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cronos Group | 721.72M |
| Anavex Life Sciences | 718.22M |
| Avanos Medical | 713.88M |
| Oculis Holding AG | 713.48M |
| Relay Therapeutics | 713.05M |
| Erasca | 692.68M |
| Immunome | 691.58M |
| Evolus | 688.30M |